Case Based Panel Discussion NSCLC – Does a Positive HER2 Mutation Effect Treatment Decisions?

Case Based Panel Discussion NSCLC – Does a Positive HER2 Mutation Effect Treatment Decisions?

User Photo
cancergrace

5 months
8 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.
Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center.
Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.

The doctors discuss a series of cases related to a diagnosis of NSCLC. In this video, the discussion is regarding a patient with a HER2 mutation, what is the clinical significance, and how does a positive HER2 mutation effect treatment decisions?

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Up Next Autoplay